BOSTON SCIENTIFIC CORPORATION (BSX)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 168% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 11.1% — below-average profitability
- Revenue growing at 20% annually
BOSTON SCIENTIFIC CORPORATION (BSX) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $102.6 billion . Key value metrics: P/E ratio 38.1, P/B ratio 4.23, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
BOSTON SCIENTIFIC CORPORATION — Fundamental Analysis Summary
BOSTON SCIENTIFIC CORPORATION (BSX) is currently trading 168% above its Graham Number of $25.83, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 38.1x.
On financial health, BSX shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 11.1% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.48.
StockPik's composite Value Score for BSX is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BSX reports a high gross margin of 68.8% (sector average: 33.5%) and a solid operating margin of 18.5%.
BSX shows revenue growing at 20% year-over-year, with earnings growing at 56%.